» Articles » PMID: 26479310

Epigenome-modifying Tools in Asthma

Overview
Journal Epigenomics
Specialty Genetics
Date 2015 Oct 20
PMID 26479310
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a chronic disease which causes recurrent breathlessness affecting 300 million people worldwide of whom 250,000 die annually. The epigenome is a set of heritable modifications and tags that affect the genome without changing the intrinsic DNA sequence. These marks include DNA methylation, modifications to histone proteins around which DNA is wrapped and expression of noncoding RNA. Alterations in all of these processes have been reported in patients with asthma. In some cases these differences are linked to disease severity and susceptibility and may account for the limited value of genetic studies in asthma. Animal models of asthma suggest that epigenetic modifications and processes are linked to asthma and may be tractable targets for therapeutic intervention.

Citing Articles

Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy.

Trejo-Villegas O, Heijink I, Avila-Moreno F Mol Ther. 2024; 32(8):2470-2488.

PMID: 38910326 PMC: 11405180. DOI: 10.1016/j.ymthe.2024.06.026.


Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes.

Skrgat S, Harlander M, Janic M Biomedicines. 2024; 12(1).

PMID: 38255279 PMC: 10813771. DOI: 10.3390/biomedicines12010173.


Early Prediction of Asthma.

Romero-Tapia S, Becerril-Negrete J, Castro-Rodriguez J, Del-Rio-Navarro B J Clin Med. 2023; 12(16).

PMID: 37629446 PMC: 10455492. DOI: 10.3390/jcm12165404.


Inhaled drug delivery for the targeted treatment of asthma.

Boboltz A, Kumar S, Duncan G Adv Drug Deliv Rev. 2023; 198:114858.

PMID: 37178928 PMC: 10330872. DOI: 10.1016/j.addr.2023.114858.


Pathogenesis of allergic diseases and implications for therapeutic interventions.

Wang J, Zhou Y, Zhang H, Hu L, Liu J, Wang L Signal Transduct Target Ther. 2023; 8(1):138.

PMID: 36964157 PMC: 10039055. DOI: 10.1038/s41392-023-01344-4.


References
1.
Woodruff P, Modrek B, Choy D, Jia G, Abbas A, Ellwanger A . T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009; 180(5):388-95. PMC: 2742757. DOI: 10.1164/rccm.200903-0392OC. View

2.
Barnes P . Theophylline. Am J Respir Crit Care Med. 2013; 188(8):901-6. DOI: 10.1164/rccm.201302-0388PP. View

3.
Asai-Tajiri Y, Matsumoto K, Fukuyama S, Kan-O K, Nakano T, Tonai K . Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma. Respir Res. 2014; 15:132. PMC: 4216659. DOI: 10.1186/s12931-014-0132-z. View

4.
Zhou L, Lopes J, Chong M, Ivanov I, Min R, Victora G . TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008; 453(7192):236-40. PMC: 2597437. DOI: 10.1038/nature06878. View

5.
Kruidenier L, Chung C, Cheng Z, Liddle J, Che K, Joberty G . A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012; 488(7411):404-8. PMC: 4691848. DOI: 10.1038/nature11262. View